{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:01:48Z","timestamp":1786539708374,"version":"build-2736575974"},"reference-count":24,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Janssen Vaccines & Prevention"},{"name":"Janssen Vaccines & Prevention B.V."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/21645515.2024.2327747","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T05:11:47Z","timestamp":1711343507000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1080","volume":"20","author":[{"given":"Neil","family":"Goldstein","sequence":"first","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"McLean","sequence":"additional","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auguste","family":"Gaddah","sequence":"additional","affiliation":[{"name":"Janssen Research & Development","place":["Beerse, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Doua","sequence":"additional","affiliation":[{"name":"Janssen Research & Development","place":["Beerse, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babajide","family":"Keshinro","sequence":"additional","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bus-Jacobs","sequence":"additional","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hendriks","sequence":"additional","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Luhn","sequence":"additional","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Robinson","sequence":"additional","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macaya","family":"Douoguih","sequence":"additional","affiliation":[{"name":"Janssen Vaccines & Prevention B.V","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,3,24]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)33132-5"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0147-3"},{"key":"e_1_3_7_4_1","unstructured":"Centers for Disease Control and Prevention. History of Ebola disease outbreaks. 30 Aug 2023. [accessed 2023 Dec 12]. https:\/\/www.cdc.gov\/vhf\/ebola\/history\/chronology.html."},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.03.008"},{"key":"e_1_3_7_6_1","unstructured":"European Commission. Vaccine against Ebola: commission grants new market authorisations. Press release. European Commission: 2020 Jul 1 [accessed 7 Jul 2023]. https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/IP_20_1248."},{"key":"e_1_3_7_7_1","unstructured":"European Medicines Agency. Zabdeno summary of product characteristics. [accessed 2023 Jul 7]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zabdeno-epar-product-information_en.pdf."},{"key":"e_1_3_7_8_1","volume-title":"Mvabea summary of product characteristics","author":"European Medicines Agency","unstructured":"European Medicines Agency. Mvabea summary of product characteristics. [accessed 2023 Jul 7]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mvabea-epar-product-information_en.pdf."},{"key":"e_1_3_7_9_1","unstructured":"World Health Organization. WHO prequalification of medical products (IVDs medicines vaccines and immunization devices vector control): Zabdeno. [accessed 2024 Feb 12]. https:\/\/extranet.who.int\/prequal\/vaccines\/p\/zabdeno."},{"key":"e_1_3_7_10_1","unstructured":"World Health Organization. WHO prequalification of medical products (IVDs medicines vaccines and immunization devices vector control): Mvabea. [accessed 2024 Feb 12]. https:\/\/extranet.who.int\/prequal\/vaccines\/p\/mvabea."},{"key":"e_1_3_7_11_1","first-page":"197","article-title":"Meeting of the strategic advisory group of experts on immunization, 22\u201324 March 2021: conclusions and recommendations","volume":"22","author":"World Health Oranization","year":"2021","unstructured":"World Health Oranization. Meeting of the strategic advisory group of experts on immunization, 22\u201324 March 2021: conclusions and recommendations. Wkly Epidemiol Rec. 2021;22:197\u2013216.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4218"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz071"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003813"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003865"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30476-X"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00125-0"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00128-6"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200072"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00594-1"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.10.055"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215457"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac445"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00402-8"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1215302"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2024.2327747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:28:59Z","timestamp":1744651739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2024.2327747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,24]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/21645515.2024.2327747"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2024.2327747","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2327747"}}